|
Volumn 7, Issue 6, 2000, Pages
|
Antidiabetic drugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACARBOSE;
ALPHA GLUCOSIDASE;
ANTIOBESITY AGENT;
CALCIUM;
CHLORPROPAMIDE;
GLIBENCLAMIDE;
GLICLAZIDE;
GLIMEPIRIDE;
GLIPIZIDE;
GLIQUIDONE;
GLUCOSE;
HEMOGLOBIN A1C;
INSULIN;
METFORMIN;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;
PIOGLITAZONE;
REPAGLINIDE;
ROSIGLITAZONE;
SIBUTRAMINE;
SULFONYLUREA DERIVATIVE;
SULFONYLUREA RECEPTOR;
TETRAHYDROLIPSTATIN;
THIAZOLIDINE DERIVATIVE;
TOLAZAMIDE;
TOLBUTAMIDE;
TROGLITAZONE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG CHOICE;
DRUG INHIBITION;
DRUG RECEPTOR BINDING;
EUROPE;
GASTROINTESTINAL SYMPTOM;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERGLYCEMIA;
INSULIN RELEASE;
INSULIN RESISTANCE;
ISCHEMIC HEART DISEASE;
LIVER TOXICITY;
MORBIDITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
ORAL GLUCOSE TOLERANCE TEST;
PANCREAS ISLET CELL FUNCTION;
POSTPRANDIAL STATE;
REVIEW;
RISK FACTOR;
|
EID: 0034126799
PISSN: 09696113
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (12)
|
References (33)
|